Circulating Levels of MiRNAs From 320 Family in Subjects With Lipodystrophy: Disclosing Novel Signatures of the Disease.
circulating biomarker
gene ontology
kobberling
lipodystrophy subtypes
metabolism
miRNA
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
01
2022
accepted:
05
05
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Lipodystrophy (LD) indicates a group of rare disorders, with generalized or partial loss of white adipose tissue (WAT) often associated with metabolic derangements. Heterogeneity/wide spectrum of the disease and lack of biomarkers make diagnosis often difficult. MicroRNAs are important to maintain a correct WAT function and WAT is a source of circulating miRNAs (cmiRs). miRNAs from 320 family were previously detected in the WAT and variably associated to the metabolic syndrome. Our aim was then to investigate if LD can result in altered abundance of cmiRs-320. We collected samples from a cohort of LD subjects of various subtypes and from age matched controls. Use of quantitative PCR determined that cmiRs- 320a-3p, 320b, 320c, 320e are upregulated, while 320d is downregulated in LD. CmiRs-320 power as classifiers was more powerful in the most extreme and defined forms of LD, including the generalized and the Dunnigan subtypes. cmiR-320a-3p showed significant inverse relationships with plasma leptin (P < 0.0001), typically low in LD. The hepatic enzymes gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and the marker of inflammation C-reactive protein (CRP) were inversely related to cmiR 320d (P < 0.05, for CRP and GGT; P < 0.01, for AST and ALT). Gene ontology analysis revealed cell-cell adhesion as a process regulated by 320 miRNAs targets, thus disclosing a novel route to investigate origin of WAT loss/dysfunction. In conclusion, cmiRs-320 constitute novel biomarkers of LD, abundance of miR320a-3p is inversely associated to indicators related to WAT function, while downregulation of cmiR-320d predicts an altered hepatic profile and higher inflammation.
Identifiants
pubmed: 35733784
doi: 10.3389/fendo.2022.866679
pmc: PMC9207177
doi:
Substances chimiques
Biomarkers
0
Circulating MicroRNA
0
MicroRNAs
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
866679Informations de copyright
Copyright © 2022 Dattilo, Ceccarini, Scabia, Magno, Quintino, Pelosini, Salvetti, Cusano, Massidda, Montanelli, Gilio, Gatti, Giacomina, Costa, Santini and Maffei.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Metabolism. 2017 Jul;72:109-119
pubmed: 28641778
Aging Cell. 2010 Oct;9(5):667-84
pubmed: 20701600
Nat Cell Biol. 2011 Jul 10;13(8):958-65
pubmed: 21743466
Dis Model Mech. 2012 Sep;5(5):588-94
pubmed: 22915020
Obesity (Silver Spring). 2008 Oct;16(10):2379-87
pubmed: 18719645
J Clin Res Pediatr Endocrinol. 2019 Aug 22;12(1):17-28
pubmed: 31434462
J Clin Lab Anal. 2020 Jun;34(6):e23239
pubmed: 32125733
Cancer Med. 2014 Aug;3(4):878-88
pubmed: 24902858
Nature. 2017 Feb 23;542(7642):450-455
pubmed: 28199304
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
J Physiol. 2014 Sep 15;592(18):4083-96
pubmed: 25038241
Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt B):1968-1983
pubmed: 28739173
Mol Metab. 2021 Mar;45:101147
pubmed: 33359386
Physiol Rev. 2021 Jul 1;101(3):907-993
pubmed: 33356916
Front Pediatr. 2021 Feb 16;9:629346
pubmed: 33665176
Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797
pubmed: 27823605
Cell Death Dis. 2014 Oct 30;5:e1499
pubmed: 25356868
RNA. 2016 Oct;22(10):1510-21
pubmed: 27473170
Sci Rep. 2018 Jul 18;8(1):10875
pubmed: 30022109
J Antimicrob Chemother. 2014 Nov;69(11):3067-75
pubmed: 25063777
Clin Exp Pharmacol Physiol. 2009 Sep;36(9):e32-9
pubmed: 19473196
Exp Clin Endocrinol Diabetes. 2021 Feb;129(2):131-137
pubmed: 31634961
Mol Ther Nucleic Acids. 2018 Sep 7;12:146-157
pubmed: 30195754
Ann Clin Biochem. 2018 Jul;55(4):437-445
pubmed: 28920467
Cells. 2020 Aug 23;9(9):
pubmed: 32842478
JCI Insight. 2021 Sep 22;6(18):
pubmed: 34383714
J Endocrinol Invest. 2019 Jan;42(1):61-73
pubmed: 29704234
Diabetes. 2014 Dec;63(12):4045-56
pubmed: 25008181
Endocrinol Metab Clin North Am. 2004 Jun;33(2):305-31
pubmed: 15158521
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Methods. 2013 Jan;59(1):S1-6
pubmed: 23036329
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511
pubmed: 27710244
J Clin Invest. 2014 Aug;124(8):3339-51
pubmed: 24983316
Diagn Interv Radiol. 2017 Nov-Dec;23(6):428-434
pubmed: 29044029
J Endocrinol Invest. 2020 Jul;43(7):983-993
pubmed: 31965518
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1099-1108
pubmed: 30418556
Int J Biol Sci. 2021 Jan 1;17(2):402-416
pubmed: 33613101
Cell Res. 2008 Oct;18(10):997-1006
pubmed: 18766170
Curr HIV Res. 2011 Jan;9(1):31-9
pubmed: 21198431
Adipocyte. 2015 Jan 20;4(3):222-4
pubmed: 26257995
PLoS One. 2017 Jun 22;12(6):e0176596
pubmed: 28640911
Orphanet J Rare Dis. 2020 Jan 15;15(1):17
pubmed: 31941540
Medicine (Baltimore). 2003 Mar;82(2):129-46
pubmed: 12640189
JCI Insight. 2019 Jul 11;4(13):
pubmed: 31292295
Endocrine. 2016 Nov;54(2):411-421
pubmed: 27473102
Nat Rev Mol Cell Biol. 2019 Aug;20(8):457-473
pubmed: 31182865
Int J Biochem Cell Biol. 2010 Aug;42(8):1273-81
pubmed: 20026422
Diabetes Care. 2003 Jun;26(6):1819-24
pubmed: 12766116
Rev Endocr Metab Disord. 2022 Feb;23(1):87-101
pubmed: 33822303
Mol Metab. 2016 Apr 11;5(6):422-432
pubmed: 27257602